Literature DB >> 1750008

The Steffee variable screw placement system using different methods of bone grafting.

K Yashiro1, T Homma, Y Hokari, Y Katsumi, H Okumura, A Hirano.   

Abstract

Two groups of patients with diseased lumbar spines treated by the Steffee variable screw placement system were studied, in order to compare concomitant posterolateral fusion and posterior lumbar interbody fusion. The use of posterolateral fusion resulted in less invasiveness than posterior lumbar interbody fusion, with regard to operating time and blood loss. With the posterolateral fusion method, correction of olisthesis or kyphotic deformity, if attained at all, was difficult to maintain. Posterior lumbar interbody fusion produced better correction and maintenance, even in osteoporotic cases. Bone union was achieved at an average of 11 months in only 60% of the posterolateral fusion group, whereas it was complete within a significantly shorter period (average; 6 months) in 91% of the posterior lumbar interbody fusion group. Breakage or loosening of screws occurred in 14% of the posterolateral fusion group. Deep wound infection and adhesive arachnoiditis, which were never seen in the posterolateral fusion group, developed in 3% of the posterior lumbar interbody fusion group. Posterior lumbar interbody fusion is considered to be a better method of bone grafting than posterolateral fusion, when used with the Steffee variable screw placement system.

Entities:  

Mesh:

Year:  1991        PMID: 1750008     DOI: 10.1097/00007632-199111000-00014

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  9 in total

Review 1.  Pedicle screw fixation in spinal disorders: a European view.

Authors:  N Boos; J K Webb
Journal:  Eur Spine J       Date:  1997       Impact factor: 3.134

2.  Minimally invasive multi-level posterior lumbar interbody fusion using a percutaneously inserted spinal fixation system : technical tips, surgical outcomes.

Authors:  Hyeun Sung Kim; Keun Ho Park; Chag Il Ju; Seok Won Kim; Seung Myung Lee; Ho Shin
Journal:  J Korean Neurosurg Soc       Date:  2011-11-30

Review 3.  The leptomeninges as a critical organ for normal CNS development and function: First patient and public involved systematic review of arachnoiditis (chronic meningitis).

Authors:  Carol S Palackdkharry; Stephanie Wottrich; Erin Dienes; Mohamad Bydon; Michael P Steinmetz; Vincent C Traynelis
Journal:  PLoS One       Date:  2022-09-30       Impact factor: 3.752

4.  Comparison of plain radiographs with CT scan to evaluate interbody fusion following the use of titanium interbody cages and transpedicular instrumentation.

Authors:  Rajesh R Shah; Saeed Mohammed; Asif Saifuddin; Benjamin A Taylor
Journal:  Eur Spine J       Date:  2003-05-07       Impact factor: 3.134

5.  Comparison between Instrumented Mini-TLIF and Instrumented Circumferential Fusion in Adult Low-Grade Lytic Spondylolisthesis : Can Mini-TLIF with PPF Replace Circumferential Fusion?

Authors:  Jin-Sung Kim; Dong-Hyun Kim; Sang-Ho Lee
Journal:  J Korean Neurosurg Soc       Date:  2009-02-28

6.  Do autologous growth factors enhance transforaminal lumbar interbody fusion?

Authors:  Hwan T Hee; Mohammad E Majd; Richard T Holt; Leann Myers
Journal:  Eur Spine J       Date:  2003-05-22       Impact factor: 3.134

7.  Particular Features of Surgical Site Infection in Posterior Lumbar Interbody Fusion.

Authors:  Jin Hak Kim; Dong Ki Ahn; Jin Woo Kim; Go We Kim
Journal:  Clin Orthop Surg       Date:  2015-08-13

8.  Improvement of Segmental Lordosis in Transforaminal Lumbar Interbody Fusion: A Comparison of Two Techniques.

Authors:  James W Rice; Cara L Sedney; Scott D Daffner; Justin W Arner; Sanford E Emery; John C France
Journal:  Global Spine J       Date:  2015-07-29

9.  Simultaneous Lateral Interbody Fusion and Posterior Percutaneous Instrumentation: Early Experience and Technical Considerations.

Authors:  Doniel Drazin; Terrence T Kim; J Patrick Johnson
Journal:  Biomed Res Int       Date:  2015-11-16       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.